ArticleFrontiers in oncology2023

Case report: Successful use of mepolizumab for immune checkpoint inhibitors-induced hypereosinophilic syndrome in two patients with solid malignancies.

Chiara Lazzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.